Dexcom today announced a significant product launch as another continuous glucose monitor (CGM) is hitting the market.

Dexcom今天宣布推出一款重要产品，另一款连续血糖监测仪（CGM）即将上市。

The San Diego-based company designed Stelo, a small, wearable sensor, specifically for people with type 2 diabetes who do not use insulin. Stelo features a 15-day wear based on the G7 platform. It offers a software experience tailored specifically for non-insulin users.

这家位于圣地亚哥的公司专门为不使用胰岛素的2型糖尿病患者设计了一种小型可穿戴传感器Stelo。Stelo基于G7平台，拥有15天的穿着体验。它提供专门为非胰岛素用户量身定制的软件体验。

Dexcom said Stelo makes it easier for the target population to access CGM and offers an option for those who don’t have insurance coverage for CGM.

Dexcom说，Stelo使目标人群更容易获得CGM，并为那些没有CGM保险的人提供了一种选择。